Escolar Documentos
Profissional Documentos
Cultura Documentos
& 2006 Nature Publishing Group All rights reserved 1466-4879/06 $30.00
www.nature.com/gene
REVIEW
Within the past few years, the focus on cytokine single nucleotide polymorphism (SNP) function and association with human
diseases has increased considerably. This third supplement to the Cytokine Gene Polymorphism in Human Disease: On-line
database describes the positive associations of cytokine SNPs in human diseases described in articles published from 2002 up
to 2005. A file containing a list of all SNPs investigated in this period of time and their association with human disease or
expression pattern can be downloaded from the internet address http://www.nanea.dk/cytokinesnps/. The web pages also
contain other features and downloads that could be useful when planning cytokine SNP association studies.
Genes and Immunity (2006) 7, 269276. doi:10.1038/sj.gene.6364301; published online 27 April 2006
Keywords: cytokine; SNP; polymorphism; variation; disease; expression
Introduction
The Cytokine Gene Polymorphism in Human Disease:
on-line database was first published in Genes and
Immunity in 1999.1 The first update, supplement 1, came
in 20012 and supplement 2 in 2002.3 Supplement 3
updates the database with articles from 2002 to early
2005. As the number of articles investigating cytokine
single nucleotide polymorphism (SNP)disease associations has increased substantially in the past few years
and as this supplement covers more than 1 year, we have
chosen only to show the SNPs that have an association
with a specific disease in Table 1. A full version of
supplement 3 is available for download from the on-line
database at the new permanent web address www.
nanea.dk/cytokinesnps/. This version includes links to
PubMed as well as the SNPs that was not found to be
associated with a disease. A few changes have been
made in this supplement compared to earlier issues, the
most prominent one being that the data are presented in
a Microsoft Excel spreadsheet, allowing the reader to
search and sort the SNPs, authors and diseases. With
regard to naming of the SNPs, we have chosen to use the
OMIM gene names (http://www.ncbi.nlm.nih.gov) and
furthermore, we have grouped those SNPs that have
numerous names under one name. For example, TNFA
308 G4A is also known as TNF NcoI or TNF1/2: in this
Correspondence: MV Hollegaard, Department of Clinical Biochemistry, Statens Serum Institut, Artillerivej 5, Copenhagen 2300,
Denmark.
E-mail: mvh@ssi.dk
Received 2 March 2006; accepted 9 March 2006; published online 27
April 2006
270
Yes
Acute appendicitis
Acute lung injury
Acute lymphoblastic leukemia
Acute rejection
Acute renal failure
Acute resistance exercise
Aggressive lymphoma
Aggressive periodontitis
AIDS
Alcoholism
Allergic asthma
Atherogenesis
Atherosclerosis
Atopic asthma
Atopic eczema
Atopic rhinitis
Atopy
Atrial fibrillation
Atrophic gastritis
Attention-deficit4hyperactivity
disorder
AV fistula patency
Basal cell carcinoma
Behcets disease
Be-hypersensitivity
Bipolar I disorder
Bladder cancer
Bladder tumors
Blood pressure
Body mass index
Bone marrow transplantation
Bone mineral density
Brain arteriovenous
malformation
Breast cancer
Bronchial asthma
Bronchopulmonary dysplasia
C. pneumoniae infection
Calcific aortic stenosis
Cardiac surgery
Cardiovascular disease
Carotid atherosclerosis
Carotid intimal-medial wall
thickness
IL10 1117 T4C, IL6 174 C4G, IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C, IL1A 889 C4T,
IL1B +3953 C4T, IL1B 511 C4T, IL1RN 86 bp VNTR, IL6 174 C4G, IL6 30 UTR VNTR, TNF 1032
T4C, TNF 857 C4T, TNF 863 C4A
IL1B 511 C4T
PAI1 675 4G45G
IL1RN 30735 T4C, IL1RN 31017 G4C, IL1RN 86 bp VNTR
IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C, IL12B +4237 G4A, IL12B +6402 A4C, IL12B
promoter, IL15 +10504 A4G, IL15 +13687 C4A, IL15 +14035 A4T, IL15 +267 C4T, IL15 +367 G4A, IL18
137 G4C, IL1B 511 C4T, IL3 +79 T4C, IL4 33 C4T, IL4 590 C4T, IL4 int3 70 bp VNTR, IL4R
+1902 G4T, IL8 251 T4A, TLR4 +896 A4G, TNF 1032 T4C, TNF 307 G4A, TNF 857 C4T, TNF
863 C4A
TLR4 +896 A4G
IL6 174 C4G
CCL5 403 G4A, haplotypes TNF24DRB1*03 TNF24*B1*1104, IL4R +148 A4G, IL4R +1902 G4T,
IL4R 3223 C4T, TNF 307 G4A, IL12B 1188 A4C, IL13 +2044, IL13 +4257 G4A, IL13 1111 C4T,
IL4 590 C4T, IL4R +148 A4G, IL4R 3223 C4T
IL4R +1902 G4T
IL4R 1432 T4C
IL13 +2044, IL18 137 G4C, IL18 607 C4A, IL1A +4845 G4T, IL1RN 86 bp VNTR, IL4R +1902 G4T
IL6 174 C4G
IL1B 31 T4C
IL1RN 86 bp VNTR
TGFB1 869 C4T, TGFB1 915 G4C
MTHFR +677 C4T
TNF 1032 T4C, TNF 237 G4A, IL1A 889 C4T, IL1B +3953 C4T
TNF 307 G4A, TNF 857 C4T
TNF 307 G4A
IL4 int3 70 bp VNTR, TNF 307 G4A, VEGF 2578 C4A
TNF 307 G4A
IL1B 511 C4T, TNF 307 G4A
IL6 174 C4G, IL6 CA repeat, TNF 307 G4A
IL1A 889 C4T, IL1B 511 C4T, TGFB1 869 C4T, TGFB1TII 1167 C4T, TNF 1032 T4C, TNF 857
C4T, TNF 863 C4A, TNFRSF1B +676 G4T
CCR2 +190 G4A, IL10 627 C4A, IL1RN 86 bp VNTR, IL6 174 C4G, IL6 572 G4C, IL6 634 C4G,
IL6 CA repeat, LTA +252 A4G, OPG 209 G4A, OPG 245 T4G, OPG A163G, PLOD1 +84 G4A, PLOD1
1097 G4A, PLOD1 1406 T4C, PLOD1 1734 C4T, PLOD1 1832 A4C, PLOD1 1988 G4T, PLOD1 2324
T4C, PLOD1 2333 C4G, PLOD1 494 C4T , PLOD1 495 G4A, PLOD1 G-86A, PLOD1 T-17G, TNF 1032
T4C, TNF 307 G4A, TNF 857 C4T, TNF 863 C4A, TNFRSF1B +1663 G4A, TNFRSF1B +1668
T4G, TNFRSF1B +1690 T4C, TNFRSF1B +593 G4A, TNFRSF1B +598 T4G, TNFRSF1B +620 T4C,
TNFRSF1B +676 G4T, VDR 2 C4T
IL6 174 C4G
IL6 174 C4G
IL5 703 C4T
TNF 307 G4A
CD14 260 C4T
IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C
TNF 307 G4A
IL10 1117 T4C, IL6 174 C4G, TGFB1 915 G4C
IL1RN 86 bp VNTR
IL6 174 C4G
271
Table 1 Continued
Disease
Yes
272
Table 1 Continued
Disease
Yes
Febrile convulsion
Febrile seizures
Focal segmental
glomerulosclerosis
Fulminant hepatitis
Gastric adenocarcinoma
Gastric cancer
IL1RN 86 bp VNTR
IL1B 511 C4T
IL10 1117 T4C
Gastric carcinoma
Gastric diseases
Gastric inflammation
Gastric mucosa-associated
lymphoid tissue lymphoma
Gastroesophageal reflux disease
Generalized aggressive
periodontitis
Glaucoma
Glucose tolerance
Glucose-6-phosphate
dehydrogenase deficiency
Graft-versus-host disease
Graves disease
Hematological malignancies:
toxic complications
Hashimoto thyroiditis
Hayfever/atopy
HCV infection
HCV viral clearance
HCV-induced cirrhosis
Heart rate
Helicobacter pylori infection
Helicobacter pylori seropositivity
Helicobacter pylori-associated
diseases
Henoch-Schonlein purpura
Hepatitis B vaccination
Hepatitis B virus
273
Table 1 Continued
Disease
Yes
CRP +1059 G4C, ICAM1 K469E, IL1B 511 C4T, IL1RN 86 bp VNTR, IL6 174 C4G, MCP1 2518
A4G, MIF 173 G4C, MMP3 1171 5A46A, TNF 307 G4A
IL13 R110Q, IL1B +3962 T4C, IL4 1098 T4G, IL6 174 C4G, MICA microsat., MIF 173 G4C, TNF
307 G4A, TNFa microsat.
TNF +851 A4G
IL6 174 C4G, IL8 251 T4A, CD14 159 C4T, VEGF 634 C4G
IL6 174 C4G, IL6 599 A4G
TNF 307 G4A
TNF 307 G4A
IL6 174 C4G
IL6 174 C4G
TNF 307 G4A
TNF 307 G4A
TNF 307 G4A
TNF 307 G4A
IL10 2763 C4A, IL10 2849 A4G, IL10 3575 T4A
TNF 237 G4A
TNF 307 G4A
LTA +252 A4G, TNF 307 G4A
IFNG +874 A4T, IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C, IL6 174 C4G, TGFB1 915 G4C,
TNF 307 G4A
IL8 251 T4A
IL10 +1668 A4T
IFNG intron 1 CA rep.
IL1B 511 C4T, MCP1 2518 A4G, TNF 307 G4A
IL12B 1188 A4C, IL12B promoter, IL1A +4845 G4T, IL1B +3953 C4T, IL4 int3 70 bp VNTR, iNOS 954
G4C
IL1B 511 C4T
IFNG +874 A4T, IL10 1117 T4C
IL10 1117 T4C, IL1B 511 C4T, IL1RN +2018 T4C, IL1RN 86 bp VNTR, IL6 174 C4G
IL10 1117 T4C
IL1A 889 C4T, LTA +252 A4G, TNF 307 G4A
MICA microsat., TNF 307 G4A
IL1RN 86 bp VNTR
IL6 174 C4G
IL10 627 C4A
C1_3_2, C132*354, D6S265, D6S276, IFNG +5644 G4A, IFNG intron 1 CA rep., IL10 1117 T4C,
IL10.G microsat., IL1A 889 C4T, IL1B +1903, IL1B +3876, IL1B +3953 C4T, IL1B 511 C4T, IL1RN
86 bp VNTR, IL4 +2580 C4A, IL4 33 C4T, IL4 590 C4T, IL4 709 VNTR, LTA +252 A4G, MCP3 gene
CA4GA microsatellite, OPN +8090 C4T, OPN +9583 G4A, TNF 307 G4A, TNF 375 G4A, TNFa
microsat., TNFRSF1B +1668 T4G
Multiple system atrophy
IL1A 889 C4T, IL1B 511 C4T, IL8 251 T4A, TNF 1032 T4C
Muscle hypertrophy
IL15RA C4A exon 7
Myasthenia gravis
IL1A 889 C4T
Myelodysplastic syndrome
TNF 307 G4A
Myelopathy
IL6 634 C4G
Myocardial infarction
IL1B 511 C4T, IL6 174 C4G, PECAM1 G670R, PECAM1 N563S, PECAM1 R643G, TNFRSF1A R92Q
Narcolepsy
TNF 857 C4T
Nasal polyposis
IL1A +4845 G4T
Nasopharyngeal carcinoma
HSP702 +1267
Necrotizing enterocolitis
IL4R +1902 G4T
Neonatal morbidity
IL1RN 86 bp VNTR
Neonatal sepsis
IL6 174 C4G
Nephropathy
VEGF 2549 18 bp del4ins
Nephrotic syndrome
IL1RN 86 bp VNTR
Non-alcoholic fatty liver
TNF 237 G4A
Non-alcoholic steatohepatitis
IL1B 511 C4T
Non-Hodgkins lymphoma
TNF 307 G4A
Nonimmunologic post-transplant TGFB1 915 G4C, IL10 1117 T4C, IFNG +874 A4T
complications: diabetes
Obesity
IL6 174 C4G, IL6R +3944 T4G, IL6R c_1158918_10, IL6R c_30046_10, IL6R rs1138004, IL6R rs1138006,
TNF 307 G4A
Oesophagitis
IL1B 511 C4T, IL1RN 86 bp VNTR
Oral lichen planus
IFNG +5644 G4A, TNF 307 G4A
Oral submucous fibrosis
TNF 307 G4A
274
Table 1 Continued
Disease
Yes
Osseointegrated implants
Ossification
Osteoarthritis
Osteolysis
Osteomyelitis
Osteoporosis
Ovarian cancer
Ozone-induced change in lung
function
Parkinsons disease
Paroxysmal nocturnal
hemoglobinuria aplastic anemia
Patchy alopecia areata
Pemphigus foliaceus
Peri-implant bone loss
Periodontal disease
Periodontitis
Peripheral artery occlusive
disease
Peritoneal adhesions
Peyronies disease
Placental inflammation
Plasmodium falciparum
reinfections
Pneumococcal septic shock
Postoperative complications
PPROM
PR3-ANCA vasculitis
Preeclampsia
Preterm birth
Preterm delivery
Preterm newborns
Preterm premature rupture of
membrane
Primary open-angle glaucoma
Prostate cancer
Psoriasis
Psoriasis vulgaris
Psoriatic arthritis
Pulmonary tuberculosis
Recurrent aphthous stomatitis
Recurrent hepatitis C virus
Recurrent pregnancy loss
Recurrent spontaneous abortion
Reflux nephropathy
Renal allograft rejection
Renal cell carcinoma
Renal parenchymal scarring
Renal transplant outcome
Renovascular disease
Respiratory syncytial virus
Response to early rheumatoid
arthritis treatment
Restenosis
Retinal artery occlusion
Rheumatic heart disease
Rheumatoid arthritis
275
Table 1 Continued
Disease
Yes
Sarcoidosis
CCL5 403 G4A, IFNG intron 1 CA rep., IL18 137 G4C, IL18 607 C4A, IL1A 889 C4T, TNF 857
C4T
CTLA4 +49 A4G, IL10 627 C4A, IL10 GCC homozygotes, IL1B 511 C4T, IL1RN 86 bp VNTR, LTA
+252 A4G, TNF 307 G4A
TNF 863 C4A
IL10 137 G4C, IL10 627 C4A, IL1RN 86 bp VNTR, LTA +252 A4G
TNF 307 G4A
HSP702 +1267, LTA +252 A4G, TNF 307 G4A
IL6 174 C4G
CD14 159 C4T
TNF 307 G4A, TNF 1032 T4C, TNF 857 C4T, TNF 863 C4A
IL1B 511 C4T
TNF 307 G4A
IL10 1117 T4C
IL1RN 86 bp VNTR
IL1B 511 C4T
IFNG +2109 A4G, IFNG +3810 G4A
IL1B +3953 C4T
IL10 1117 T4C, TLR4 +896 A4G, TNF 307 G4A
TNF 237 G4A, TNF 307 G4A, TNF 375 G4A
IL6 174 C4G
MCP1 2518 A4G
Schizophrenia
Scleroderma
Sepsis
Sepsis mortality
Septic shock
Septicemia
Serum lipoproteins
Severe acute pancreatitis
Severe Alzheimers
Severe aplastic anemia
Severe chronic periodontitis
Severe dementia
Severe gastric inflammation
Severe hepatic fibrosis
Severe rheumatoid arthritis
Severe sepsis
Severe silicosis
Severe stroke
Severity of HCV-related liver
disease
Sjogrens syndrome
Smoking
Spondyloarthropathy
Spontaneous abortions
Spontaneous preterm birth
Stroke
Subacute sclerosing
panencephalitis
Sudden infant death syndrome
Synthetic hemodialysis graft
failure
Systemic lupus erythematosus
CCR5 32-bp del., TNF 307 G4A, IL1B 31 T4C, IL1B 3877, IL1B 511 C4T
mono-S-RCCX-TNF2 haplotype, IL6 174 C4G
CD14 159 C4T
IL1RN 86 bp VNTR
IL4 590 C4T, TNF 307 G4A, IL6 174 C4G
IL4 590 C4T, PAI1 +11053 T4G
IL4 590 C4T
IL6 1753 C4G, IL6 174 C4G, IL6 2954 G4C haploypes
TNF 307 G4A
C4AQ0, CCL5 28 C4G, IL10 1117 T4C, IL10 Haplotype 3575 T 2763C 1082A 819 T 592A,
IL1A +4845 G4T, IL1A 889 C4T, IL1B +3953 C4T, IL1B 511 C4T, IL1RN 86 bp VNTR, IL8 845
T4C, MBL2 G57E, MBL2 221 X4Y, MBL2 550 H4L, MBL2 G54D, MBL2 R52C, MCP1 2518 A4G,
OPN +1239 A4C, OPN 156 G del., TNF 307 G4A
TNF 307 G4A
IL1A +4729 T4C, IL1A +4845 G4T, IL1A 889 C4T, MCP1 2518 A4G
IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C, TNF 1032 T4C, TNF 237 G4A, TNF 307 G4A,
TNFa microsat., TNFd microsat., TNFd microsat.
IL12B int. 2 ATT, IL12B promoter, intron 2, intron 4, 30 UTR haplotypes, IL12RB1 haplotype 2: 641G 684 T
1094C 1132C, TNF 237 G4A, TNF 307 G4A
IL10 1117 T4C, IL10 627 C4A, IL10 854 T4C, IL12B int. 2 ATT, IL12B +1159 C4A, IL4R +1124
A4C, IL4R +1417 G4T, IL4R +1466 T4C, IL4R +148 A4G, IL4R +1682 T4C, IL4R +1902 G4T, IL4R
+676 C4T, IL4R 3223 C4T, IL4R S761P haplotypes, TNF 307 G4A, TNF microsat., IL1B +3953 C4T,
IL6 174 C4G, IL18 137 G4C, IL18 607 C4A, TNFRSF1A 383 A4C
APM1 haplotype 11391 11377, IL6R +48867 A4C, TNF 307 G4A, IL6 174 C4G, TNF 863 C4A,
CD14 159 C4T
IL11.A142 dinucleotide rep., IL1RN 86 bp VNTR, MIF 173 G4C, TNF 237 G4A, TNF 307 G4A
TNF 307 G4A
LTA +365 G4C, TNF 237 G4A
IL1B +3953 C4T
TLR4 +896 A4G
OPG 950 T4C
TNF 307 G4A
IL1RN 86 bp VNTR
IL1B +3953 C4T, IL1RN 86 bp VNTR
LTA +252 A4G, TNF 307 G4A
IL10 1117 T4C, IFNG +874 A4T, TNF 237 G4A
276
Figure 1 Screenshot from the Links Navigator page on the Cytokine Gene Polymorphism in Human Disease website showing a part of the
new design.
References
1 Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T,
McDermott MF et al. Cytokine gene polymorphism in human
disease: on-line databases. Genes Immun 1999; 1: 319.
2 Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T,
McDermott MF et al. Cytokine gene polymorphism in human